Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYN-020 Phase 1 MAD Study in Healthy Subjects
NCT05045833Phase 1Completed
- Sponsor
- Theriva Biologics
- Start
- Oct 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules, Replacement Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of intestinal alkaline phosphatase in radiation enteritis (5 arms), sponsored by Theriva Biologics. Primary endpoints: SYN-020 systemic absorption and SYN-020 presence in feces. Started Oct 2021; status: completed.
02
Drugs
intestinal alkaline phosphatase
03
Conditions
radiation enteritis
Beyond the preview
Go deeper on NCT05045833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05045833.